Nucleus Biologics, The Cell Performance Company™, a top provider of custom cell culture media and buffers for the cell and gene therapy sector, is excited to introduce its new QuickStart Media™ platform. This innovative platform accelerates the formulation and manufacturing of custom media, enhancing its already extensive range of cell culture products and solutions. QuickStart Media™ underscores Nucleus Biologics’ commitment to streamlining the delivery of custom cell culture media, buffers, reagents, and services with greater efficiency and speed.
QuickStart Media™ was designed to give scientists a head start in developing high-performing custom media. Each QuickStart Media formulation is optimized for specific cell types or functions, yet fully customizable in components and packaging to meet researchers’ precise needs and critical quality attributes (CQAs). This offering uniquely combines the convenience of ready-made media with the flexibility of custom solutions, enhancing performance and supply chain consistency through transparent licensing.
Key Features of QuickStart Media:
- Diverse Applications: Initially includes NB-KUL™ 10 for cryopreservation of T cells, HEK cells, MSCs, and NK cells, with NB-ROC™ serum-free T-cell media and HEKima™ Adherent SF media launching soon. Additional media for NK cells, MSCs, and a DMSO-free cryomedia are in development.
- Proven Performance: Built on years of research, these formulations have been rigorously tested against leading media providers.
- Customizable: Allows modification of media composition to fit specific experimental needs, improving accuracy and relevance.
- Technical Support: Comprehensive assistance in optimizing formulations and addressing any issues.
- Licensing Options: Ensures transparency in media components and consistency of supply.
David Sheehan, President and CEO of Nucleus Biologics, stated, “QuickStart Media offers proven formulations that can be optimized and licensed, providing unprecedented transparency. This flexibility accelerates research and speeds up the process of getting therapies into clinical use. Our goal is to help scientists understand their media and optimize their therapies, ultimately leading to faster cures.”
Nucleus Biologics is dedicated to advancing scientific research with high-quality cell culture solutions. Their portfolio of premium reagents, media, and buffers supports diverse research needs and fosters innovation in the biotechnology and pharmaceutical industries.
